Granzyme K Activates Protease-Activated Receptor-1
Author Information
Author(s): Dawn M. Cooper, Dmitri V. Pechkovsky, Tillie L. Hackett, Darryl A. Knight, David J. Granville
Primary Institution: Institute for Heart and Lung Health, St. Paul's Hospital, Vancouver, British Columbia, Canada
Hypothesis
GrK induces pro-inflammatory cytokine release through the activation of protease-activated receptors.
Conclusion
Extracellular GrK is capable of activating PAR-1 and inducing fibroblast cytokine secretion and proliferation.
Supporting Evidence
- GrK induced secretion of IL-6, IL-8, and MCP-1 in a dose- and time-dependent manner.
- Heat-inactivated GrK did not induce cytokine release, indicating that protease activity is required.
- GrK activated both the ERK1/2 and p38 MAP kinase signaling pathways.
- Inhibition of ERK1/2 abrogated the GrK-mediated cytokine release.
- PAR-1 is essential for GrK-induced IL-6, IL-8, and MCP-1 release.
Takeaway
Granzyme K helps cells in the lungs release substances that cause inflammation, which can be important for healing but may also lead to problems if not controlled.
Methodology
The study used cultured human lung fibroblasts to assess the effects of extracellular GrK on cytokine release and signaling pathways.
Potential Biases
Potential bias due to the specific focus on GrK without considering other factors influencing inflammation.
Limitations
The study does not explore the long-term effects of GrK on lung inflammation or its role in chronic diseases.
Participant Demographics
Human lung fibroblasts were used, but specific demographic details of the source are not provided.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website